Moksha8 Finds New Life for Old Drugs in Latin America

In late 2008, a startup called Moksha8 convinced Pfizer (PFE) to do an unusual deal in Brazil. In exchange for a cut of sales, Moksha8 would promote a decades-old antibiotic called Vibramycin, along with several other brands in Pfizer’s portfolio of older drugs no longer protected by patents. Forecasting declining sales against competition from lower- [...]